(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics Cancer >  2023 Competing in the European Cancer Diagnostics Market:
France, Germany, Italy, Spain, UK

2023 Competing in the European Cancer Diagnostics Market:
France, Germany, Italy, Spain, UK




This new report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.  During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field.  Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.  The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Table of Contents

I.       Introduction

II.      Worldwide Technology and Market Overview

             A.  Cancer Statistics and Etiology

             B.  Major Current and Emerging Cancer Diagnostics Tests

             C.  Instrumentation Review and Market Needs

             D.  Current and Emerging Technologies

III.     France

IV.     Germany

V.      Italy

VI.     Spain

VII.    U.K.

VIII.    Major Product Development Opportunities

IX.      Alternative Market Penetration Strategies

X.       Design Criteria for Decentralized Testing Products

XI.      Potential Market Entry Barriers and Risks

XII.     Competitive Assessments

XIII.    Appendix
                                                 



To order sections of this report, contact Client Services


     
   
Local PDF: $7500.00
Other Formats: Global PDF, DataPack
   
   
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X